"Still, the FDA refuses to take action.
No new warnings are planned and prescriptions for Ritalin continue to spiral upward.
Objections to the FDA's sluggishness are even starting to appear in conservative medical journals like JAMA, the Journal of the American Medical Association. In a recent editorial, they criticized the FDA by saying the FDA is "interpreting the results cautiously."
Plus, JAMA notes that the FDA funded and approved the design of the study. Only when results came out did they have a problem with the design of the study. I guess the FDA didn't like the results their own design produced."